Common stock, 0.01 par value, 40,000,000 shares authorized, 36,815,725 shares issued and 36,778,545 shares outstanding at september 30, 2026, and 29,315,726 shares issued and 29,278,546 outstanding at december 31, 2025
368,157
301,490
293,157
293,157
Series e convertible preferred stock, 0.0001 par value, 1,552,795 shares authorized, issued and outstanding
2,500,000
2,500,000
2,500,000
2,500,000
Preferred rights
40,000
40,000
40,000
40,000
Additional paid-in-capital
75,125,230
71,991,896
70,351,574
70,168,395
Treasury stock, 37,180 shares each period, at cost
95,023
95,023
95,023
95,023
Accumulated other comprehensive loss
-4,144,732
-8,310,012
-8,027,374
-8,647,513
Accumulated deficit
-66,628,307
-62,189,471
-62,819,821
-65,353,966
Total stockholders' equity (deficiency)
7,165,325
4,238,880
2,242,513
-1,094,950
Total liabilities, temporary equity and stockholders' equity (deficiency)
64,652,738
61,745,657
58,824,602
57,596,586
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.